CAPRIN1 and cancer: The specificity of cancer cell membrane binding anti-CAPRIN-1 antibodies we generated was confirmed by (i) competition assays using soluble recombinant CAPRIN-1 and (ii) abolished binding to CAPRIN-1–deficient cancer cells following CAPRIN-1 knockdown.